Dopamine receptors: from structure to function
- PMID: 9457173
- DOI: 10.1152/physrev.1998.78.1.189
Dopamine receptors: from structure to function
Abstract
The diverse physiological actions of dopamine are mediated by at least five distinct G protein-coupled receptor subtypes. Two D1-like receptor subtypes (D1 and D5) couple to the G protein Gs and activate adenylyl cyclase. The other receptor subtypes belong to the D2-like subfamily (D2, D3, and D4) and are prototypic of G protein-coupled receptors that inhibit adenylyl cyclase and activate K+ channels. The genes for the D1 and D5 receptors are intronless, but pseudogenes of the D5 exist. The D2 and D3 receptors vary in certain tissues and species as a result of alternative splicing, and the human D4 receptor gene exhibits extensive polymorphic variation. In the central nervous system, dopamine receptors are widely expressed because they are involved in the control of locomotion, cognition, emotion, and affect as well as neuroendocrine secretion. In the periphery, dopamine receptors are present more prominently in kidney, vasculature, and pituitary, where they affect mainly sodium homeostasis, vascular tone, and hormone secretion. Numerous genetic linkage analysis studies have failed so far to reveal unequivocal evidence for the involvement of one of these receptors in the etiology of various central nervous system disorders. However, targeted deletion of several of these dopamine receptor genes in mice should provide valuable information about their physiological functions.
Similar articles
-
[Dopamine receptors--structure, characterization and function].Postepy Hig Med Dosw. 2003;57(3):293-322. Postepy Hig Med Dosw. 2003. PMID: 14524248 Review. Polish.
-
Dopamine receptors and brain function.Neuropharmacology. 1996;35(11):1503-19. doi: 10.1016/s0028-3908(96)00100-1. Neuropharmacology. 1996. PMID: 9025098 Review.
-
The renal dopamine receptors.J Am Soc Nephrol. 1992 Feb;2(8):1265-78. doi: 10.1681/ASN.V281265. J Am Soc Nephrol. 1992. PMID: 1627751 Review.
-
Multiple dopamine receptors: the D3 receptor and actions of substances of abuse.EXS. 1994;71:81-92. doi: 10.1007/978-3-0348-7330-7_9. EXS. 1994. PMID: 8032175 Review.
-
The dopaminergic system in hypertension.Clin Exp Hypertens. 2001 Jan-Feb;23(1-2):15-24. doi: 10.1081/ceh-100001193. Clin Exp Hypertens. 2001. PMID: 11270582 Review.
Cited by
-
Modelling hemodynamics regulation in rats and dogs to facilitate drugs safety risk assessment.Front Pharmacol. 2024 Oct 29;15:1402462. doi: 10.3389/fphar.2024.1402462. eCollection 2024. Front Pharmacol. 2024. PMID: 39534082 Free PMC article.
-
Bacteriocin Microcin J25's antibacterial infection effects and novel non-microbial regulatory mechanisms: differential regulation of dopaminergic receptors.J Anim Sci Biotechnol. 2024 Nov 13;15(1):156. doi: 10.1186/s40104-024-01115-3. J Anim Sci Biotechnol. 2024. PMID: 39533384 Free PMC article.
-
Dopamine in Sports: A Narrative Review on the Genetic and Epigenetic Factors Shaping Personality and Athletic Performance.Int J Mol Sci. 2024 Oct 29;25(21):11602. doi: 10.3390/ijms252111602. Int J Mol Sci. 2024. PMID: 39519153 Free PMC article. Review.
-
A drug repurposing screen reveals dopamine signaling as a critical pathway underlying potential therapeutics for the rare disease DPAGT1-CDG.PLoS Genet. 2024 Oct 28;20(10):e1011458. doi: 10.1371/journal.pgen.1011458. eCollection 2024 Oct. PLoS Genet. 2024. PMID: 39466823 Free PMC article.
-
D1-like dopamine receptors promote B-cell differentiation in systemic lupus erythematosus.Cell Commun Signal. 2024 Oct 17;22(1):502. doi: 10.1186/s12964-024-01885-3. Cell Commun Signal. 2024. PMID: 39420360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
